Insider trade

Officer received an award of 1,285 WST derivative securities

Traded Mar 1, 2026 · Filed Mar 3, 2026

West Pharmaceutical ServicesWST

1,285
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 1, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 3, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000105770-26-000039
Filed / recorded

Mar 3, 2026, 4:36 PM UTC

Added to OQRO

Oct 2, 2026, 12:29 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

WEST PHARMACEUTICAL SERVICES INC

Issuer CIK

105770

Ticker

WST

Reporting person

Norman D. Jr. Finch

Relationship

Officer

Officer title

SVP, GC & Corporate Secretary

Security

Rst. Stock Unit

Table

Derivative (Table II)

Transaction date

Mar 1, 2026

Transaction code

A

Shares / units

1,285

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

1,285

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of WST common stock.
The restricted stock units vest in four equal annual installments beginning on March 1, 2027.

Around the same time

6mo ago

52Derivative units · @ $250.64

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

7mo ago

3,057Derivative units

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

7mo ago

6,986Derivative units

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

Why it stands out

Dates, kept separate

Context

Source receipt

Footnotes from the filing

Around the same time

52Derivative units · @ $250.64

3,057Derivative units

6,986Derivative units

Most active this month